Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

DURECT Corporation

DRRXNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.91
$-0.02(-1.04%)
U.S. Market is Open • 14:21

DURECT Corporation (DRRX) Stock Overview

Explore DURECT Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap59.3M
P/E Ratio-17.05
EPS (TTM)$-0.43
ROE-0.71%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

DRRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of DURECT Corporation (DRRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.06, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -17.05 and a market capitalization of 59.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
205.26%
6-Month Change
155.007%
Year-to-Date (YTD) Change
141.53%
1-Year Change
46.92%
3-Year Change
-63.27%
5-Year Change
-90.26%
All-Time (Max) Change
-98.67%

Contact Information

408 777 1417
10260 Bubb Road, Cupertino, CA, 95014-4166

Company Facts

210 Employees
IPO DateSep 28, 2000
CountryUS

Frequently Asked Questions